EMAIL EMAIL
ANALYST BRIEFING
Title: Analyst Briefing: Generics to Impact North American Oral Solid Drug Dosage Excipients Market
Analyst: Nandhini Rajajgopal
Briefing Date: Jan 22 2014
Time: 11:00am EST/10:00am CST/4:00pm GMT/5:00pm CET

Short Description:

Industry Analyst Nandhini Rajajgopal completed extensive analysis on the North American Oral Solid Drug Dosage Excipients Market. The expert led a short teleconference about new findings that affect the market, followed by a live question-and-answer session.

You Will Discover:

Blockbuster drugs worth $73,850 million are expected to lose patent protection in the United States between 2009 and 2017, resulting in an influx of generic manufacturers. This briefing will investigate the increase in volume of drugs and the relative increase in excipients volume.

Why you should attend?

1. Understand the different types of excipients used in solid drug dosage forms, their price, current market size and future market scenario.
2. Learn key unmet needs and success factors for oral solid drug dosage excipients.
3. Identify the drivers and restraints of the market.

Registration:

Click on the "Play" button below to listen On Demand.

BACK TO TOP BACK TO TOP

QUICK SEARCH

GO GO
ADVANCED SEARCH
Search our research by date, market, technology, region or keywords
GO GO
SHARE
Discover how we can help your business
GO  GO
Learn how we can provide data and insight for your specific requirements
GO  GO
HELP DESK
For general assistance and enquiries:
Africa:
+27 21 680 3260
enquiries@frost.com

Asia Pacific:
+65 68900999
apacfrost@frost.com

Europe:
+44 (0)20 8996 8500
enquiries@frost.com

Israel:
+972-9-9502888
Israel@frost.com

Latin America:
+54 11 4777 1550
myfrost@frost.com

Middle East & North Africa:
+971.4.4331.893
meenquiries@frost.com

North America:
+1.877.463.7678
myfrost@frost.com

South Asia:
+91 (0) 22 6160 6666
saenquiries@frost.com

For a full list of our offices click here
Sitemap | Disclaimer | Privacy
© Frost & Sullivan
Conseq